Series date: 
Thursday, July 1, 2021 - 7:00am to Thursday, June 30, 2022 - 4:00pm
Location

Please check the individual session for location or broadcast availability.  


Frequency

Monthly


Series Director

Tannaz Armaghany, MD


Target Audience and Needs

Hematologist-oncologists, radiation oncologists, surgeons, other medical specialists, basic and translational research scientists, residents, fellows, and medical students need to be regularly updated on advances in the diagnosis and management of patients with hematologic disorders and related malignancies. The series aims to broaden the knowledge base of learners in these topic areas and improve their competencies to enhance the patient care experience and outcomes.


Educational Methods

Educational methods will include lectures and literature review.


Objectives

At the conclusion of the sessions, the participants should be able to:

  • Describe the pathophysiology and epidemiology of hematologic and related cancers.
  • Identify the challenges in diagnosing and managing specific hematologic cancers or their disease-related complications.
  • Identify the optimal standard-of-care approach for managing specific hematologic and related cancers.
  • Apply evidence-based findings from clinical trials to improve the standard of care.

Evaluation

Participants may be asked to complete a session evaluation.


Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Series Coordinator 

Christina Velasquez
cguerrer@bcm.edu
713-798-4508

Series location: 
Baylor College of Medicine
One Baylor Plaza
Houston, TX 77030
United States

Sessions